Meeting of the Uniform Formulary Beneficiary Advisory Panel, 46895 [06-6906]

Download as PDF Federal Register / Vol. 71, No. 157 / Tuesday, August 15, 2006 / Notices Standards and Technology, Gaithersburg, MD 20899, Appointment Expires: 12/31/07, Limited. Patricia Sefcik (C), Senior Director to the Deputy Assistant Secretary for Manufacturing, Manufacturing and Services, International Trade Administration, Washington, DC 20230, Appointment Expires: 12/31/ 07, General. James E. Hill (C), Director, Building and Fire Research Laboratory, National Institute of Standards and Technology, Gaithersburg, MD 20899, Appointment Expires: 12/31/2008, General. Dated: August 7, 2006. Robert Cresanti, Under Secretary for Technology, Technology Administration, Department of Commerce. [FR Doc. E6–13356 Filed 8–14–06; 8:45 am] BILLING CODE 3510–18–P Uniform Formulary as reflected in the recommendations DOD Pharmacy and Therapeutics (P&T) Committee coming out of that body’s meeting in August 2006. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at https://www.pec.ha.osd.mil. Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to baprequests@tma.osd.mil no later than September 14, 2006. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a first-come, first-served basis. The amount of time allocated to a speaker will not exceed five minutes. Privacy Act of 1974, as amended, were submitted August 3, 2006, to the House Committee on Government Reform, the Senate Committee on Homeland Security and Governmental Affairs, and the Office of Management and Budget (OMB) pursuant to paragraph 4c of Appendix I to OMB Circular No. A–130, ‘Federal Agency Responsibilities for Maintaining Records About Individuals,’ dated February 8, 1996 (February 20, 1996, 61 FR 6427). Dated: August 8, 2006. C.R. Choate, Alternate OSD Federal Register Liaison Officer, Department of Defense. DODDS 21 SYSTEM NAME: Department of Defense Dependents Schools (DODDS) Grievance Records (May 14, 1997, 62 FR 26483). Dated: August 8, 2006. C.R. Choate, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 06–6906 Filed 8–14–06; 8:45 am] CHANGES: Meeting of the Uniform Formulary Beneficiary Advisory Panel BILLING CODE 5001–06–M SYSTEM NAME: Department of Defense, Assistant Secretary of Defense (Health Affairs). ACTION: Notice of Meeting. DEPARTMENT OF DEFENSE SUMMARY: This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act. DATES: Thursday, September 21, 2006, from 8 a.m. to 4 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 2004. FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 703–681– 2890, ext. 6718, fax 703–681–1940, or email at baprequests@tma.osd.mil. SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Privacy Act of 1974; System of Records DEPARTMENT OF DEFENSE Office of the Secretary AGENCY: mstockstill on PROD1PC61 with NOTICES 46895 VerDate Aug<31>2005 15:41 Aug 14, 2006 Jkt 208001 SYSTEM IDENTIFIER: Delete entry and replace with ‘‘DoDEA 21.’’ Delete entry and replace with ‘‘Department of Defense Education Activity (DODEA) Grievance Records.’’ Office of the Secretary SYSTEM LOCATION: [DOD–2006–OS–0179] Delete name and replace with ‘‘Department of Defense Education Activity.’’ * * * * * Office of the Secretary, DoD. Notice to alter a system of AGENCY: ACTION: records. SUMMARY: The Office of the Secretary of Defense is altering a system of records to its existing inventory of record systems subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. DATES: The changes will be effective on September 14, 2006 unless comments are received that would result in a contrary determination. ADDRESSES: Send comments to the OSD Privacy Act Coordinator, Records Management Section, Washington Headquarters Services, 1155 Defense Pentagon, Washington, DC 20301–1155. FOR FURTHER INFORMATION CONTACT: Ms. Juanita Irvin at (703) 696–4940. SUPPLEMENTARY INFORMATION: The Office of the Secretary of Defense notices for systems of records subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended, have been published in the Federal Register and are available from the address above. The Proposed systems reports, as required by 5 U.S.C. 552a(r) of the PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 CATEGORIES OF RECORDS IN THE SYSTEM: Delete entry and replace with ‘‘The system contains records relating to grievances and arbitrations filed by DoDEA employees with the Agency, with the Office of Special Counsel, the Office of Personnel Management, or the Federal Labor Relations Authority. Includes records relating to the identity of third parties, pleadings, statements of witnesses, investigative reports, interviews, hearings, hearing examiner’s findings and recommendations, copies of decisions relating to the grievance, and other relevant correspondence and exhibits.’’ AUTHORITY FOR MAINTENANCE OF THE SYSTEM: Delete entry and replace with ‘‘5 U.S.C. 1221, 2302, and 7532; 10 U.S.C. 2164; 20 U.S.C. 901–907; 20 U.S.C. 931; E.O. 9397 (SSN); 5 CFR 771; DoD Directive 1342.2, Department of Defense Education Activity; and DoDEA 5771.9, Administrative Grievance Procedures.’’ PURPOSE(S): Delete first paragraph and replace with ‘‘To maintain records for use by E:\FR\FM\15AUN1.SGM 15AUN1

Agencies

[Federal Register Volume 71, Number 157 (Tuesday, August 15, 2006)]
[Notices]
[Page 46895]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6906]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Thursday, September 21, 2006, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 2004.

FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management 
Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory 
Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 
703-681-2890, ext. 6718, fax 703-681-1940, or e-mail at 
baprequests@tma.osd.mil.

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the Uniform 
Formulary as reflected in the recommendations DOD Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
August 2006. The P&T Committee information and subject matter 
concerning drug classes reviewed for that meeting are available at 
https://www.pec.ha.osd.mil. Any private citizen is permitted to file a 
written statement with the advisory panel. Statements must be submitted 
electronically to baprequests@tma.osd.mil no later than September 14, 
2006. Any private citizen is permitted to speak at the Beneficiary 
Advisory Panel meeting, time permitting. One hour will be reserved for 
public comments, and speaking times will be assigned only to the first 
twelve citizens to sign up at the meeting, on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed 
five minutes.

    Dated: August 8, 2006.
C.R. Choate,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 06-6906 Filed 8-14-06; 8:45 am]
BILLING CODE 5001-06-M

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.